Form 8-K - Current report:
SEC Accession No. 0001367644-24-000053
Filing Date
2024-04-26
Accepted
2024-04-26 16:30:22
Documents
18
Period of Report
2024-04-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ebs-20240423.htm   iXBRL 8-K 32324
2 EX-10.1 kerpamendment2024.htm EX-10.1 11383
6 kerpamendment2024001.jpg GRAPHIC 245816
7 kerpamendment2024002.jpg GRAPHIC 264351
8 kerpamendment2024003.jpg GRAPHIC 264960
9 kerpamendment2024004.jpg GRAPHIC 46919
  Complete submission text file 0001367644-24-000053.txt   1309297

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ebs-20240423.xsd EX-101.SCH 1967
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ebs-20240423_lab.xml EX-101.LAB 22804
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ebs-20240423_pre.xml EX-101.PRE 13102
21 EXTRACTED XBRL INSTANCE DOCUMENT ebs-20240423_htm.xml XML 2819
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 24884351
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)